Apollo Hospitals Enterprise Limited (AHEL) on Friday announced that its Promoter Group, represented by Managing Director Ms. Suneeta Reddy, has sold 1,897,239 equity shares of the company through a block deal on the stock exchanges. The transaction, executed at ₹7,850 per share, represents a 1.3% stake in the company and was priced at about a 1% discount to Thursday’s closing price.
Following this sale, the Promoter Group’s shareholding in Apollo Hospitals will come down to around 28% from 29.3% earlier. Importantly, the pledged holdings of the Promoter Group as a percentage of their total holding will reduce sharply from 13.1% to nearly 2%. The proceeds from the stake sale will be used to repay outstanding debt, fulfilling a prior commitment to investors to lower pledged shares.
Morgan Stanley India Company Private Limited acted as the selling broker for the transaction.
The company clarified that the Promoter Group remains fully committed to Apollo Hospitals and its other healthcare ventures — Apollo HealthCo and Apollo Health and Lifestyle. They reiterated their focus on long-term value creation in each vertical and stressed that there are no plans for further stake reduction in the foreseeable future.
Apollo Hospitals is one of India’s largest and most trusted healthcare providers, with a strong presence across hospitals, pharmacies, primary care, diagnostics, and digital health platforms.
